Cancer chemotherapeutic alkylating agents (e.g. BCNU,) act by inducing formation of lethal cross € damage it can tolerate. In normal tissues, MGMT acts as a suppressor of mutation and carcinogenesis. Tumors with high levels of MGMT are likely to be drug resistant
Applications
IHC-P
Positive Control
Jurkat or MCF-7 cells. Human tonsil or stomach (IHC).
Dilutions
IHC: 1-2 µg/ml
Reactivity
Human
Immunogen
Recombinant fragment (around Amino Acids 1-100) of human MGMT. The exact sequence is proprietary.
Host
Rabbit
Clonality
Monoclonal
Clone ID
MGMT/8364R
Isotype
IgG
Light Chains
kappa
Conjugate
Unconjugated
Purification
Protein A/G chromatography.
Concentration
200 µg/ml
Molecular Weight
21.646 kDa
Product Form
Liquid
Formulation
Supplied in 10mM Phosphate Buffered Saline with 0.05% BSA and 0.05% Sodium Azide.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.